Skip to main content

Beyond Nila

Trusted newsletters, papers, podcasts and tools.

Non-commercial, clinician-built or independently edited. No affiliate links, no paid placement. Updated roughly every quarter.

Beyond Nila

Newsletters and decision tools we trust

Non-commercial, clinician-built or independently edited. Useful for a second source or when a friend asks 'where else can I read about this?'

  • Newsletter

    The Vajenda

    by Dr. Jen Gunter

    Free Substack. Reliably good at debunking the latest 'bioidentical' or compounded-pellet claim before it spreads.

  • Newsletter

    Hotflash Inc.

    by Ann Marie McQueen

    Long-running newsletter and podcast covering the menopause beat as actual journalism — including which products and claims don't hold up.

  • Tool

    MyMenoPlan

    by UCSF & Massachusetts General Hospital (NIH-funded)

    A free decision tool built by menopause researchers: short symptom checker, personalized plan covering hormonal and non-hormonal options.

  • Tool

    Endocrine Society — Menopause patient library

    by The Endocrine Society

    The endocrinology profession's own patient-facing reference. Strong on the hormone-system side and a useful cross-check.

No affiliate links. No paid placement. We update this shelf roughly every quarter.

Beyond Nila

Landmark papers and reference docs

The professional documents and journal pieces clinicians cite. Useful when you want to read the actual source behind the guidance.

  • Paper

    The [w]Health Employer Index 2026

    by Kearney (Paula Bellostas Muguerza, Anna Bode, Kate Maheu, Betty Pio)

    While most employers have taken initial steps on women's health, true maturity requires integrated action connecting policy to lived experience through better communication, data use, and employee feedback.

  • Paper

    Mega Menopause Survey 2025 / MM25

    by Menopause Mandate (with UCL support)

    15,000+ women across the UK on what menopause support actually looks like: what's improved, what's still missing, and where urgent change is needed. Patient-led data at a scale most clinical cohorts don't reach.

  • Paper

    Bridging the Gender Gap in Health Care Innovation: The Evolution of FemTech

    by Jenny Castillo Cato, MD, FACEP (JMIR)

    As FemTech matures into a $97B market, the priority must be deep, inclusive innovation that addresses chronic conditions and dismantles gender bias in research.

  • Paper

    The Veradigm 2026 Women's Health Report

    by Veradigm (Alina B., Isabelle Winer, Kate Cappell)

    With data from 148M+ patients, this report surfaces sobering gaps: from the surging adolescent mental health crisis to the fact that fewer than 1 in 10 eligible women receive HRT. A powerful call to bridge the evidence-to-practice gap.

  • Paper

    Global Fertility Report 2026

    by Emmeline Ventures (La Keisha Landrum Pierre, Azin Radsan van Alebeek, Blessing Chukwuneke)

    With 257 companies analyzed, this report highlights a stark funding gap: women founded nearly 60% of these firms, yet they receive only 32.5% of disclosed funding. Essential reading for understanding where venture capital is, and is not, placing its bets on reproductive health.

  • Paper

    The Persons Project: Breaking the Cycle

    by The Persons Project (a My Normative initiative)

    Synthesizes interviews with leaders across FemTech, academia, clinical research and life sciences to map the women's health knowledge gap, the vicious cycle of stagnation it creates, and a coordinated response: an open data ontology, shared research infrastructure, and an annual investment report.

  • Paper

    The 2022 Hormone Therapy Position Statement

    by The Menopause Society (NAMS)

    The current professional consensus document. Dense, but it's the thing your doctor's guidelines are based on.

  • Paper

    Vaginal estrogen use in breast cancer survivors

    by Crandall et al., Menopause (NAMS), 2017

    The reference clinicians cite when discussing local vaginal estrogen for GSM after breast cancer. Cross-link from /treatments/cancer-risk.

  • Paper

    ADHD, perimenopause and the case for clinical recognition

    by de Jong et al., 2023

    One of the first peer-reviewed pieces naming the pattern clinicians are now seeing in clinic.

  • Paper

    The Women's Health Innovation Radar (2026)

    by World Economic Forum, Kearney Health Institute, Gates Foundation, Wellcome Leap

    Maps where women's health innovation is actually happening across funding, evidence and product pipelines. Names menopause as under-resourced relative to disease burden.

No affiliate links. No paid placement. We update this shelf roughly every quarter.

Beyond Nila

Hosts we trust, off-site

Standing recommendations beyond any one episode. The shows we'd hand a friend who wants to settle in for the long haul.

  • Podcast

    You Are Not Broken

    by Dr. Kelly Casperson

    Urologist, sex-positive, talks about MHT and testosterone in midlife in plain language. Strong on libido and GSM.

  • Podcast

    The Hit Play Not Pause Podcast

    by Selene Yeager

    Active midlife women, training and recovery angles, with guests who actually research this population.

  • Podcast

    ADHD for Smart Ass Women

    by Tracy Otsuka

    Has multiple episodes on the perimenopause–ADHD collision. The hosts and guests get it from the inside.

  • Podcast

    Divergent Conversations

    by Dr. Megan Anna Neff and Patrick Casale

    AuDHD-affirming. Not menopause-specific, but useful when the standard CBT-for-perimenopausal-anxiety advice doesn't translate.

  • Podcast

    Menopause After Cancer

    by Dr. Deborah Lee

    UK-based, oncology-aware, with episodes that name the trade-offs honestly rather than defaulting to 'no MHT, ever'.

No affiliate links. No paid placement. We update this shelf roughly every quarter.